Is The Proof of an Additional Benefit under amnog in Germany More Difficult for Certain Drugs than for Other Ones?
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.1607
https://www.valueinhealthjournal.com/article/S1098-3015(15)03683-9/fulltext
Title :
Is The Proof of an Additional Benefit under amnog in Germany More Difficult for Certain Drugs than for Other Ones?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)03683-9&doi=10.1016/j.jval.2015.09.1607
First page :
A523
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
1038